Healthy Returns: AstraZeneca proposes U.S. drug price cuts to Trump
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing market with new free offering.| CNBC
AstraZeneca's CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing market with new free offering.| CNBC
| newsroom.ap.org
